Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00761787 · ClinicalTrials.gov registry record

Cardiac Allograft Rejection Gene Expression Observational (CARGO) II STUDY

A clinical trial of Heart Disease and Graft Rejection, sponsored by XDx.

Completed
Registry status
800
Enrollment target
17
Study locations

NCT00761787 is a study of Heart Disease and Graft Rejection that has completed, run by XDx. The registered enrollment target is 800 participants, below the 2,021-participant average among 31 other Heart Disease trials with a reported enrollment target (60% lower). The trial reports 17 study locations across 17 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00761787, a study of Heart Disease and Graft Rejection, has completed, sponsored by XDx.

COMPLETED
Registry status
800 participants
Enrollment target
17
Study locations

Study Summary

The Cardiac Allograft Rejection Gene Expression Observational (CARGO) II Study is designed to provide independent evidence of the clinical performance of the non-invasive AlloMap test. Sensitive detection of cardiac allograft rejection and dysfunction is the basis for successful recipient management. The CARGO II Study will assess the correlation between the presence or absence of acute cellular rejection as determined by examination of endomyocardial biopsy specimens with results from the AlloMap Test. Of 17 participating transplant centers, 4 are in North America and 13 are in Europe.

Conditions Studied

Heart Disease Graft Rejection

Study Locations (17)

Minnesota

  • University of Minnesota - Minneapolis

New York

  • Columbia University Medical Center - New York

Texas

  • Texas Heart Institute - Houston

Innsbruck

  • Medizinische Universität Innsbruck, Klinische Abteilung für Herzchirurgie - Anichstrasse 35

Vienna

  • Medical University of Vienna (Medizinische Universität Wien) - Währinger Gürtel 18-20

Leuven

  • UZ Gasthuisberg - Herestraat 49

Ontario

  • Toronto General Hospital - Toronto

Paris

  • Hospital La Pitie - 47 Bd de L

Trial Details

FieldValue
Enrollment Target 800 participants
Start Date 2005-05
Est. Completion 2009-02

Sponsor

XDx

3 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00761787

The ClinicalTrials.gov registry entry for NCT00761787 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 800 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,021-participant average among 31 other Heart Disease trials with a reported enrollment target (60% lower). The listed sponsor is XDx, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Heart Disease appearing as the primary indexed condition, and to 0 interventions.

NCT00761787 reports 17 study locations spanning 17 distinct geographic areas - top geographies include Minnesota, New York, Texas.

Frequently Asked Questions

What is clinical trial NCT00761787 about?

NCT00761787 is a clinical study titled "Cardiac Allograft Rejection Gene Expression Observational (CARGO) II STUDY". The Cardiac Allograft Rejection Gene Expression Observational (CARGO) II Study is designed to provide independent evidence of the clinical performance of the non-invasive AlloMap test. Sensitive detection of cardiac allograft rejection and dysfunction is the basis for successful recipient management...

What is the current status of trial NCT00761787?

This trial is currently completed. The enrollment target is 800 participants. The study started on 2005-05. Estimated completion is 2009-02.

What conditions does trial NCT00761787 study?

This clinical trial studies the following conditions: Heart Disease, Graft Rejection.

Who is sponsoring clinical trial NCT00761787?

This trial is sponsored by XDx, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00761787 being conducted?

This trial has 17 study locations across Minnesota, New York, Texas, Innsbruck, Vienna. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Heart Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Heart Disease

All registered trials for this condition

Graft Rejection

All registered trials for this condition

Minnesota

All trials with a study site in Minnesota

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.